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1. Introduction 
ESRV Elective Surgical Revascularization is the ultimate intervention in atherosclerotic 
aorto-iliac disease which has progressed up to the arterial insufficiency state [1]. Surgical 
solution of extreme forms of aorto-iliac atherosclerotic disease (such as aortic aneurysm) 
implies removal of the stenotic/dilated arterial segment, creation of an arterial derivation, 
and/or placement of a vascular prosthesis [2]. Surgical act entails a metabolic aggression 
whose cost might override the patient’s homeostatic mechanisms, resulting in complications 
and death [3-4]. Consequently, the medical team should care for the safe completion of the 
surgical procedure through identification and proactive modification of factors existing in 
the patient that might place him/her at risk of complication and death. 
Patient’s nutritional status can determine the result of surgical activity. An increased risk of 
surgical failures has been reported as patient’s nutritional status deteriorates [5-7]. However, 
relationship between the response to the surgical act and nutritional status might not be that 
straightforward, and could be modified by fuzzy variables such as age and presence of co-
morbidities [8-9].  
The present essay gives the opportunity for assessing the relationship between nutritional 
status of the patient and surgical activity from a different, entirely new, perspective. That is: 
it would be interesting to examine if body weight excess can also modify the results of 
surgical activity non-related to tumor-reduction, as would be the case of ESRV. This study 
model of systemic response to surgical aggression could be more appealing in view of the 
fact that abnormalities of the great abdominal vessels intended to be surgically corrected 
represent different stations in the progression of atherosclerotic disease, and this, in turn, is 
associated with Obesity. Thus, it could be anticipated that surgical failures rate to increase 
as patient’s body fat does. 
2. Atherosclerosis and nutrition 
Any discussion on the possible links between atherosclerotic aorto-iliac disease and 
nutrition should take into account the influence of subject’s food habits upon onset and 
history (in absence of intervention) of this illness, the nutritional status of the patient prior to 
ESRV, and nutritional influence upon the response to the surgical act. 
Atherosclerosis is intimately related with disorders of blood lipids homeostasis [10-11]. 
Although fat strip has been described as the originary atherosclerotic lesion in the aorta of 
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newborn babies, its conversion into an atheroma, with subsequent calcification, rupture and 
thrombosis, or weakening of the arterial wall, are all associated with chronic states of 
hypercholesterolemia [11-12]. However, it should be noticed that causes of 
hypercholesterolemia can be multiple and chaotic in their presentation and influences [13].  
Obesity, established from the disproportionate participation, and anomalous distribution, of 
body fat in the subject’s body composition, and the repercussion that specified 
topographical locations of adipose tissue have upon endocrine activity of human economy 
as well as cell and tissue metabolism, is an important factor in the progression of 
atherosclerotic damage [14-15]. Obesity results from the incapacity of the organism to 
correctly use food energy quantities incongruent with subject’s physical activity, in 
particular if present in his/her regular diet as refined sugars and energetically dense foods. 
Coincidently, elevated food fats intakes, with an important participation of saturated fats 
and trans fatty acids, have been described in obese subjects [15-18]. Hypercholesterolemia 
could also be the result of unbalanced intakes of long-chain, poly-unsaturated fatty acids, 
and poor representation of 3 fatty acids in the diet [13,19]. All these food influences 
converge to configure the so-called Metabolic syndrome, which eventually leads to 
hyperuricemia, blood lipids disorders, and disruption of the peripheral utilization of 
carbohydrates, that might evolve towards hyperglycemia and insulin resistance; molecular 
events all that accelerate the progression of atherosclerotic disease [20-21]. 
 
 
Legends: S: Saturated fats. P: Poly-unsaturated fats. ORSs: Oxygen-reactive species 
Fig. 1. Some influences in the progression of the originary atherosclerotic lesion. The figure 
intends to  call the attention upon factors involved in atherosclerosis dependant on Obesity 
as well as molecular defects in LDL-Cholesterol clearance. The presentation does not 
exhaust the events related with atherosclerosis, nor the relationships they sustain among 
them. For further details: See pertinent references at the end of the essay. 
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3. Nutritional phenotypes in atherosclerotic aorto-iliac disease 
Corresponding with what has been said previously, it should not come as a surprise to see 
that a significant proportion of aorto-sclerosis patients considered for ESRV show a body 
weight higher that the one expected regarding the height of their peers, as seen in Figure 2. 
Regarding BMI Body Mass Index, 69 patients assisted between 2000 – 2007 due to aorto-iliac 
atherosclerosis (more than half presenting with aortic aneurysm) at a Angiology and 
Vascular surgery of a referral, tertiary hospital of the city of Havana (Cuba) were distributed 
as follows: Malnourished: < 18.5 Kg.m-2: 4.3%; Non-Malnourished: Between 18.5 – 24.9 
Kg.m-2: 41.4%; and Body weight excess: > 24.9 Kg.m-2: 54.3%; respectively. Fourteen point 2 
percent of the patients was obese on admission to the Service.  
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Legend: BMI: Body Mass Index.  
Source: Records of the Nutritional Support Group. Clinical surgical Hospital “Hermanos Ameijeiras”. 
La Habana. Cuba. 
Records closed on: Monday, October 10th, 2010. 
Fig. 2. Distribution of different nutritional phenotypes among patients awaiting elective 
surgical revascularization in a referral, tertiary, Angiology service. More than half of 
patients presented with aortic aneurysm. 
Having reached this point in the essay, a relevant question is pertinent: Can body weight 
excess (in either of its two forms: overweight or obesity) affect the response to ESRV? In 
other words: does the risk of complications after ESRV increase because of size/distribution 
of body fat? If this is to be the case, patient’s response to ESRV could be improved, and in 
the process, a higher-quality medical-surgical care offered, by means of the conduction of 
proactive measures oriented to modify the size as well as topographical distribution of body 
fat. 
The relevance of these considerations is not to be ignored. ESRV includes technically-
demanding procedures, such as aorto-femoral derivation, and placement of vascular 
prostheses. Complications that might occur after completion of such procedures can 
encompass from sepsis to derivation/prosthesis failure, with subsequent amputation of the 
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vascular compromised limb [3-4,22]. Interestingly, considerations about the association 
between surgical activity and nutritional status have been dominated by the discussion on 
how weight loss affects the result of surgical tumor-reduction [5-8]. On the contrary, 
documented evidences on the influence of body weight excess upon the response of the 
patient to surgical activity non-related with oncology practice are scarce. However, it has 
been hypothesized that the relationship between risk of complication after a surgical act and 
nutritional status of the patient might adopt a “U” or “J” shape, as shown in Figure 3 [23-
24]. The shape of this relationship is striking, because it stresses that polar nutritional 
phenotypes can be equivalent in their influences upon the response of the patient to the 
surgical activity1.  
 
 
Drawn with data taken from: References [23-24]. 
Fig. 3. Influence of nutritional phenotype upon response to the surgical act. 
4. Why polar nutritional phenotypes are equally deleterious for the response 
to ESRV? 
ENM Energy Nutrient Malnutrition is that disorder of body composition resulting from 
depletion of Potassium-rich, metabolic-active, lean tissues [26]. Reduction of body lean mass 
beyond a critical size is associated with an increased risk of complications after ESRV, not to 
                                                 
1 Unfortunately, the author has not been able to validate this hypothesis. After research completed in a 
Angiology and Vascular Surgery referral, tertiary Service, it was concluded that post-surgical 
complications were independent from nutritional phenotype, affecting two-thirds of non-malnourished 
patients, and half plus one of those with body weight excess [25]. 
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mention death2. ENM deeply affects all the orders of subject’s economy, and profoundly 
alters inner milieu homeostasis. Malnutrition usually associates with impaired liver protein 
synthesis and tissue repair and healing processes, and defective collagen deposition, thus 
difficulting the formation of an effective scar callous [24, 27]. Malnutrition also brings about 
disruption of the natural barriers for restraining invading pathogen bacteria, antigen-
presentation mechanisms, production and release of cytokines, immunoglobulins and cell 
mobilization factors, and the proliferation and differentiation of cells involved in immune 
response [28]. Far from exhausting the topic, malnutrition can affect ventilatory function, 
making the subject prone to failure in weaning from a mechanical ventilator and pneumonia 
[29]; as well as kidney function, thus altering depuration of toxins and other by-products of 
tissue metabolism [30]. 
By comparison, influence of body weight excess upon response to surgical activity has been 
little explored, above all in settings non-related with tumor-reduction. Excess of 
subcutaneous adipose tissue can result in an increased rate of surgical wound sepsis due to 
failure in obliterating the incision line, and subsequent appearance of dead spaces. Poor 
vascularity of subcutaneous adipose tissue can also contribute to an insufficient irrigation of 
surgically lacerated tissues, and thus, inflammation, bacterial colonization, and surgical 
wound sepsis. Suture dehiscence, incisional hernias and eventrations could then become the 
most visible face of the influence of body weight excess upon surgical activity. 
But body weight excess can also exert remote influences through altered states of peripheral 
utilization of carbohydrates. Indeed, hyperglycemia has been described as a post-surgical 
sepsis risk factor [31]. It is to be kept in mind that cells involved in immune response are 
important consumers of energy as glucose [32]. Hyperglycemia can result from disorders in 
the peripheral utilization of carbohydrates as well as hyper-insulinism states. Insulin action 
target-cell can express a reduced number of hormone-specific receptors, or uncouple the 
receptor from post-receptor cascade of events, inhibiting in one way or the other stimulation 
by insulin, a phenomenon recognized as “down-regulation”. Incapacity of using glucose as the 
energy substrate of choice forces the cell to turn to alternative energy fuels, which in the end, 
worsens hypertrigliceridemia resulting from improper cell utilization of metabolic energy. 
Body weight excess can be also associated with chronic states of inflammation. Depending on 
the topographical location, the adipocyte is able to produce cytokines (TNF Tissue Necrosis 
Factor among them), and other inflammation-promoting molecules [33]. These blood products 
also contribute to insulin resistance, hyperglycemia and hypertrigliceridemia. Hence, and 
given what has been said before, body weight excess can become a powerful negative 
predictor of complications after ESRV.  
5. Can age independently influence upon response to ESRV? 
Relationship between probability of complication after ESRV and nutritional phenotype has 
been documented in subjects younger than 60 years of age [23, 24]. However, such 
dependence relationship has not been established in older subjects. As a matter of fact, it has 
come to the attention of researchers that body weight excess is associated with a lesser risk 
of complications after completion of surgical acts non-related with tumor-reduction in 
                                                 
2 There is also depletion of adipose tissue in ENM, but this phenomenon is secondary to the reduction of 
the size of body lean mass. As a matter of fact, post-surgical complications can occur in a patient with a 
nearly constant adipose tissue.  
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elderly subjects [34]. In a recently concluded research at a referral, terminal Angiology 
Service, it was observed that age was an independent predictor of after-ESRV failures when 
higher complications rates concentrated among younger subjects notwithstanding 
nutritional phenotype [25]. Hence, it is only attractive to explore why age transit can cause 
such a profound transformation of the relationship discussed throughout this essay. 
Significant changes occur in subject’s body composition with aging. These changes could 
result from “turning off” molecular signals responsible for tissue accretion (explaining, at 
least in part, the phenomenon of “sarcopenia”); redistribution of body compartments, with 
preponderance of adipose tissue deposition at the scapular waist, and concomitant 
reduction of the circumference of body segments and/or substitution of body lean mass 
with adipose tissue [35]. These changes could, in turn, modify subject’s hormonal status, 
reducing insulin resistance, and thus, altered states of peripheral utilization of 
carbohydrates [36]. The morpho-functional substrate such as the one early described might 
then explain why Obesity, understood as an increase in body fat size, can act as a protecting 
factor in the third age of life. Hence, others events/circumstances aside, a subject with +60 
years of age could tolerate ESRV better if he/she presents to the surgical act with body 
weight excess, when compared with younger peers.  
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Reproduced from: Reference [25] with the authorization of the Editorial board of ANGIOLOGIA, 
bimonthly journal of the Spanish Society of Angiology and Vascular Surgery. 
Fig. 4. Complications observed after completion of ESRV in a referral, terminal Angiology 
Service. Cases are distributed according with nutritional status and age. Blue solid line: 
Complications observed in subjects younger than 60 years. Pink solid line: Complications 
observed in elder subjects. More than half of patients presented with aortic aneurysm. 
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6. On perioperatory nutritional intervention in ESRV 
Having discussed the aforementioned issues, it is time to dwell about interventions oriented 
to secure the success of ESRV by supplying the patient with selected nutrients incorporating 
intrinsic pharmacological actions, such as 3 fatty acids and dietetic fiber. 
Pharmacological actions of 3 fatty acids have been intensively studied in recent years. 3 
fatty acids, brought by oily seeds and deep waters fishes, might act as precursors of 3- and  
 
Nutrient Recommended 
intake 
Foods Enteral 
Nutrients 
Parenteral  
Nutrients 
3 fatty acids 
 DHA 
200 mg.24 h-1 Flaxseed oil 
Deep water fishes: 
herring, cod 
SUPPORTAN 3 
(Fresenius-Kabi, Germany)
NUTRICOMP IMMUN 
(BBRAUN, Germany) 
NUTRICOMP Diabetes 
(BBRAUN, Germany) 
LIPOPLUS (BBRAUN, 
Germany) 
STRUCTOLIPIDS 
(Fresenius-Kabi, 
Germany) 
3 fatty acids 
 DPA 
Not 
established 
Flaxseed oil 
Deep water fishes: 
herring, cod 
SUPPORTAN 3 
(Fresenius-Kabi, Germany)
NUTRICOMP IMMUN 
(BBRAUN, Germany) 
NUTRICOMP Diabetes 
(BBRAUN, Germany) 
LIPOPLUS (BBRAUN, 
Germany) 
STRUCTOLIPIDS 
(Fresenius-Kabi, 
Germany) 
3 fatty acids 
 EPA 
200 mg.24 h-1 Flaxseed oil 
Deep water fishes: 
herring, cod 
SUPPORTAN 3 
(Fresenius-Kabi, Germany)
NUTRICOMP IMMUN 
(BBRAUN, Germany) 
NUTRICOMP Diabetes 
(BBRAUN, Germany) 
LIPOPLUS (BBRAUN, 
Germany) 
STRUCTOLIPIDS 
(Fresenius-Kabi, 
Germany) 
Dietetic fiber 
 Soluble 
10-15 g/day Fruits, beans, 
selected vegetables
NUTRICOMP Diabetes 
(BBRAUN, Germany) 
Non available 
Dietetic fiber 
 Non-soluble 
10-15 g/day Non-digested parts 
of fruits, beans, 
vegetables 
NUTRICOMP Standard 
w/ Fibre (BBRAUN, 
Germany): 
7.5 g/500 mL 
Non available 
Glycerol Not 
established 
Lards, butter, 
margarines 
Non available LIPOFUNDIN 
LCT/MCT (BBRAUN, 
Germany): 
25 g/1000 mL 
LIPOPLUS (BBRAUN, 
Germany): 
25 g/1000 mL 
ProcalAmine 
(BBRAUN, Germany): 
25 g/1000 mL 
Legend: DHA: Docosahexanoic acid. DPA: Docosapentanoic acid. EP: Eicosapentanoic acid. 
Note: Soluble, dietetic fiber refers to mucins and pectins. Insoluble, dietetic fiber refers to cellulose and 
hemi-cellulose. 
Table 1. Nutrients known for their effect upon insulin resistance and peripheral utilization 
of sugars. It is not intended to be a comprehensive list of presented items. 
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5-series prostanoids, with documented anti-inflammatory, anti-clotting, and smooth muscle-
relaxing properties [37]. Supply of such fatty acids, be either as foods or chemically defined 
preparations, could then become an intervention resulting in a lesser systemic inflammatory 
activity, and thus, a better utilization of cell as well as tissue energy substrates [38]. Use of 
3 fatty acids as part of nutritional intervention in ESRV might also result in stabilization of 
the atherosclerotic plaque, thus facilitating the work of angiologist surgeon [39]. Morever, it 
has been reported that use of parenteral lipids solutions incorporating fish oil as a source of 
3 fatty acids shortened hospital length of stay of patients electively subjected to abdominal 
aortic aneurysm surgery [40]. However, is should be remembered that prolonged use of 3 
fatty acids might modify shape, size, distribution and lipid composition of HDL High 
density Lipoproteins that have been linked to a reduced risk of atherosclerotic damage [41].  
Dietetic fiber could be another nutrient capable to influence upon response to ESRV. Low 
dietetic fiber intakes have been described after surveys completed in obese subjects [42-43]. 
Low dietetic fiber intakes have been associated with occurrence of blood lipid disorders and 
increased peripheral resistance to insulin action [44]. Supply of dietetic fiber might improve 
cell/tissue response to insulin’s stimulatory action, and hence, altered states of 
carbohydrates peripheral utilization [45]. Likewise, dietetic fiber might also modify features 
and distribution of plasma lipoproteins in charge of Cholesterol and triglycerides 
transportation [46]. 
Finally, being hyperglycemia the first complication associated with/derived from body 
weight excess upon which to intervene after ESRV, alternative sugars solutions to Glucose 
should be made available to the angiologist surgeon for energy supply to the patient. 
Several alternative sugars have been proposed, such as xylitol, glucitol and sorbitol [47]. 
Glycerol: the poly-alcohol supplying the carbon backbone sustaining triglycerides’s 
structure, has also been proposed as an alternative substrate to Glucose in post-surgical 
settings where insulin resistance, hyperglycemia, and hypertrygliceridemia are to be 
expected [48]. 
7. Clinical case: Ischemia-reperfusion syndrome - Influence upon nutritional 
status and response to ESRV 
Complicated atherosclerosis is associated with a reduced blood irrigation of regions distal to 
atherosclerotic lesion, and hence, chronic tissue ischemia. When blood supply is restored 
after ESRV, molecular signals generated by until-that-moment ischemic tissues enter the 
blood stream. Systemic influence of such molecular signals might simulate the shock picture 
firstly described in people trapped in collapses [49]. Ischemia-reperfusion syndrome thus 
configured might affect nutritional status of patient subjected to ESRV, and complicate the 
implementation of designed nutritional support scheme. 
Case presentation: The case is presented of a 55 years-old, white female, being admitted to a 
referral, terminal Angiology and Vascular Surgery Service for surgical correction of a 
mesenteric-aorto-iliac atheromatosis. The list with health problems identified in this patient 
is displayed in Table 2. During the surgical act, an aorto-iliac derivation was made, along 
with reopening of the superior mesenteric artery and placement of a bypass. Post-surgical 
evolution was torpid, marked by a Multiple Organs Dysfunction event, local as well as 
systematic sepsis, and a SIRS Systemic Inflammatory Response System. Health problems 
presented during post-operatory follow-up were all medically treated. Eventually the 
patient overcome these problems and was discharged from the Service. 
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Pr 1. Chronic tobacco use. 
Pr 2. Complicated mesenteric-aorto-iliac Atherosclerosis. 
Pr 3. Moderate Energy Nutrient Malnutrition of the Marasmatic type. 
sPr 3.1 Sixteen Kg weight loss during the last 6 months. 
 Volitional enteral Nutrition: Generic, fiberless, polimeric diet: 400 Kcal.24 h-1 
H1: Mesenteric insufficiency. 
 Jejunum biopsy: No villous atrophy is observed. Mild congestion of lymph and 
blood vessels. 
Pr 4. Peripheral arterial insufficiency. 
sPr 4.1 Intermittent claudication. 
 Oriented pharmacological treatment. 
 Laparotomy. 
 Aortic endarteriectomy. 
 Placement of an end-to-end aortic prosthesis. 
 Aorto-iliac bypass. 
 Superior mesenteric-aortic bypass. 
Pr 5. Complicated Endarteriectomy Post-operatory Status. 
sPr 5.1 Systemic sepsis: Bacterial bronchopneumonia. 
 ATB: Cefotaxime+Gentamicine 
sPr 5.2 Local sepsis: Moniliasic glosytis 
 Nistatine mouth washes. 
Pr 6. Multiple Organ Disfunction 
sPr 6.1 Small bowel dysfunction: Diarrheas. 
 Nils per Oris 
 Central Parenteral Nutrition: Dextrose 10%: 800 Kcal.24 h-1 + Aminoacids 10%: 
50 g.24 h-1 
sPr 6.2 Lung dysfunction: Lung congestion. 
sPr 6.3 Liver dysfunction: Prolonged coagulogram. 
 K Vitamin administration. 
sPr 6.4 Heart dysfunction: Acute heart insufficiency. 
 Treatment w/ Digitalics. 
 Heart function support w/ Amines 
sPr 6.5 Bone marrow dysfunction: Anemia 
 Blood transfusion: Two 500 mL-bags of blood. 
Pr 7. SIRS Systemic Inflammatory Response Syndrome. 
sPr 7.1 Hydroelectrolitic disorders. 
sPr 7.2 Upper digestive bleeding. 
H2: Stress ulcers 
 Nils per Oris 
 Interruption of Central Parenteral Nutrition scheme. 
Table 2. Patient’s health problems listing. 
Table 3 shows the evolution of selected nutritional as well as welfare markers collected 
during the patient’s treatment window. Weight loss accentuated during post-operatory 
evolution, as expression of existing tissue catabolism. Haemoglobin values never went 
beyond the 120 g.L-1 limit. Observed anemia might compound several causes, among them, 
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insufficient supply of nutrients. A marked lymphopenia was observed, as expression of the 
immune suppression accompanying SIRS installed during post-operatory evolution. Serum 
Cholesterol values were lower than 3.5 mmol.L-1, confirming inflammatory status present in 
the patient as response to the ischemia-reperfusion syndrome. Interestingly, depletion of 
serum Albumin values was not observed, pointing to a liver function preserved enough to 
sustain nitrogen anabolism. This circumstance might explain the patient’s favorable 
evolution, in spite of recorded events. There was also constancy of serum Creatinine values, 
indicating a conserved depurative kidney function for securing inner milieu homeostasis. 
 
Day of 
Evolution 
Weight, 
Kg 
MAC, 
Cm 
Hb, 
g.L-1 
TLC, 
cél.mm3 
S-Cre, 
umol.L-1 
S-Alb, 
g.L-1 
S-Chol, 
mmol.L-1 
-58 36.0  102 2478 59.7 40.0   
-26 35.0        
-15    117  61.0 44.0 3.9 
-12 33.0 20.3       
-3 35.0 20.0       
-1    105      
0    90      
+2    111  67.6    
+3 37.0 21.0 141 1782     
+4    157 1496 53.0 32.5   
+9 40.0        
+11    75  46.6    
+12 40.0 20.0       
+13    75 1188     
+14      41.0    
+17    92 888 67.0    
+19    99  52.0  3.1 
+22    54 459     
+24    105      
+30     1320 56.0    
+37 32.0 17.0 116      
+44    109 3960 67.6 38.0 4.7 
+132 41.0        
+151     108   91.3   4.5 
Legend: MAC: Mid-arm-circumference. Hb: Hemoglobin. TLC: Total Lympochytes Count. S-Cre: Serum 
Creatinine. S-Alb: Serum Albumin. S-Chol: Serum Cholesterol. 
Table 3. Behavior of selected nutritional as well as welfare markers of the patient discussed 
in the “Clinical case presentation” section. Shaded boxes indicate abnormal values of the 
corresponding marker. See text for further details. 
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Hemodynamic instability situation experienced by the patient during post-operatory course 
prevented the installment of coherent nutritional support schemes. This can be better 
appreciated in Figure 5. Important discontinuities in the use of the oral route for sustaining 
nutritional status were observed during the 20 days following the surgical act. Bowel 
insufficiency warned against the use of enteral nutrients during this stage as a substitute for 
oral feedings. In spite of all these events, the hospital NST Nutritional Support Team always 
stood for timely rehabilitation of the oral route, and prescribed the supply of energy as low-
density Dextrose solutions. A hyperglycemia event (serum Glucose: 22.1 mmol.L-1) was 
identified on day +13 of post-surgical evolution, forcing to momentarily interrupt the 
infusion of Dextrose solutions. Eventually, once hemodynamic stability was achieved, 
organic function recovered, and sepsis foci controlled, oral route was used for satisfying 
patient’s nutrients needs. This action, along with parenteral aminoacids supplementation, 
might have been determinant in patient’s response to ESRV. 
 
 
Fig. 5. Behavior of nutritional support during follow-up of the patient discussed in “Clinical 
case presentation” section. Discontinuities in the use of oral route are represented as falls of 
the solid blue line. Conduction of artificial nutritional schemes is symbolized as surges 
arising from the corresponding baseline. See text for further details. 
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8. Conclusions 
The results of a study model of metabolic response to stress conveyed by ESRV have been 
presented in this work. Body weight excess might become a predictor of post-surgical 
complications. This hypothesis will be reformulated in future works in order to explore if 
occurrence of complications after ESRV can be traced back to the different facets of Insulin 
resistance Syndrome associated to body weight excess, such as arterial hypertension, 
hyperglycemia, blood lipid disorders, and hyperuricemia, among others. It is expected that 
complications risk to be minimal among obese patients presenting with few stigmas of 
insulin resistance, but maximal in those exhibiting a critical number of such stigmas. 
9. Final notice 
The preceding discussion has focused on the link between nutrition and aortic aneurysm as 
an extreme form of aorto-iliac atherosclerotic disease, given the involvement of the author 
with the practice of a referral, tertiary Angiology Service. However, aortic aneurysm might 
result from other, atherosclerosis-independent causes. The case is presented of a teen-ager 
suffering from an aortic aneurysm of probable mycological origin being assisted at a 
medical surgical clinic in Havana City [50]. Size of aneurysm prevented oral feeding, thus 
causing a significant nutritional derangement. Central Parenteral nutrition using premixed, 
all-in-one admixtures (NutriFlex Lipid Peri, B|BRAUN, Melsungen, Germany) was started 
in order to sustain patient’s nutritional status, and improve metabolic response to surgical 
trauma. 
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